Exercise evokes retained motor performance without neuroprotection in a mouse model of Parkinson's disease. [PDF]
Skelton HM +7 more
europepmc +1 more source
Systematic Review of the Huntington's Disease Drug Development Pipeline, 2014 to 2025
Abstract Background In the past decade, significant advances have improved our understanding of the mechanisms underlying HD pathobiology leading to several putative therapeutic targets for HD. Objective The aim was to describe the Huntington's disease (HD) drug development clinical pipeline.
Pavlina Konstantinova +5 more
wiley +1 more source
Microbiota and Guillain-Barré syndrome: role of microbial metabolites, biomarkers, and emerging therapeutic strategies. [PDF]
Zurdo-López M +4 more
europepmc +1 more source
A Curcumin-Decorated Nanozyme with ROS Scavenging and Anti-Inflammatory Properties for Neuroprotection [PDF]
Feng Gao +8 more
openalex +1 more source
Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease [PDF]
Ewelina Pałasz +5 more
openalex +1 more source
Neuroprotective Effects of RNS60 in TDP‐43 Pathology‐Associated Amyotrophic Lateral Sclerosis
ABSTRACT Introduction TDP‐43 pathology is broadly observed in the cerebral cortex of patients with amyotrophic lateral sclerosis (ALS). RNS60, an experimental treatment for acute ischemic stroke and ALS, enhanced mitochondrial biogenesis and function in other preclinical models.
Danny R. Vesevick +4 more
wiley +1 more source
GENI as an AMPK Activator Binds α and γ Subunits and Improves the Memory Dysfunction of Alzheimer’s Disease Mouse Models via Autophagy and Neuroprotection [PDF]
Ying Wang +8 more
openalex +1 more source
The NLRP3 Inflammasome: A Central Mediator in Sevoflurane-Induced Neurotoxicity and A Potential Target for Neuroprotection. [PDF]
Li N, Chen Y, Chen G.
europepmc +1 more source
Brosimine B and the biphasic dose-response: insights into hormesis and retinal neuroprotection [PDF]
Susanne Suely Santos da Fonseca +12 more
openalex +1 more source

